Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  63 نتائج ل ""Microbial Sensitivity Tests""

فلترة النتائج

Publisher : american association for the advancement of science
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics.

  • Authors : Noto Guillen M; Department of Systems Biology, University of Massachusetts Medical School, Worcester, MA, USA.; Li C

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/classification ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology

  • Source: Science (New York, N.Y.) [Science] 2024 Apr 05; Vol. 384 (6691), pp. 93-100. Date of Electronic Publication: 2024 Mar 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance.

  • Authors : Wu KJY; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.; Tresco BIC

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemical synthesis ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology

  • Source: Science (New York, N.Y.) [Science] 2024 Feb 16; Vol. 383 (6684), pp. 721-726. Date of Electronic Publication: 2024 Feb 15.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance.

  • Authors : Wang Z; Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, NY 10065, USA.; Koirala B

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Lipopeptides*/Lipopeptides*/Lipopeptides*/pharmacology; Computational Biology

  • Source: Science (New York, N.Y.) [Science] 2022 May 27; Vol. 376 (6596), pp. 991-996. Date of Electronic Publication: 2022 May 26.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.

  • Authors : Stracy M; Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.; Department of Biochemistry, University of Oxford, Oxford, UK.

Subjects: Drug Resistance, Bacterial*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacteria/Bacteria/Bacteria/*drug effects

  • Source: Science (New York, N.Y.) [Science] 2022 Feb 25; Vol. 375 (6583), pp. 889-894. Date of Electronic Publication: 2022 Feb 24.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

  • Authors : Sourimant J; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.; Lieber CM

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/*drug therapy

  • Source: Science (New York, N.Y.) [Science] 2022 Jan 14; Vol. 375 (6577), pp. 161-167. Date of Electronic Publication: 2021 Dec 02.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19.

  • Authors : Owen DR; Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA.; Allerton CMN

Subjects: COVID-19 Drug Treatment*; Lactams/Lactams/Lactams/*pharmacology ; Lactams/Lactams/Lactams/*therapeutic use

  • Source: Science (New York, N.Y.) [Science] 2021 Dec 24; Vol. 374 (6575), pp. 1586-1593. Date of Electronic Publication: 2021 Nov 02.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Replication and single-cycle delivery of SARS-CoV-2 replicons.

  • Authors : Ricardo-Lax I; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.; Luna JM

Subjects: RNA, Viral/RNA, Viral/RNA, Viral/*genetics ; Replicon/Replicon/Replicon/*physiology ; SARS-CoV-2/SARS-CoV-2/SARS-CoV-2/*genetics

  • Source: Science (New York, N.Y.) [Science] 2021 Nov 26; Vol. 374 (6571), pp. 1099-1106. Date of Electronic Publication: 2021 Oct 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Biosynthesis of fluopsin C, a copper-containing antibiotic from Pseudomonas aeruginosa .

  • Authors : Patteson JB; Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Putz AT

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*biosynthesis ; Copper/Copper/Copper/*analysis ; Pseudomonas aeruginosa/Pseudomonas aeruginosa/Pseudomonas aeruginosa/*metabolism

  • Source: Science (New York, N.Y.) [Science] 2021 Nov 19; Vol. 374 (6570), pp. 1005-1009. Date of Electronic Publication: 2021 Nov 18.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

  • Authors : Drayman N; Pritzker School for Molecular Engineering, The University of Chicago, Chicago, IL, USA. .; DeMarco JK

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Coronavirus 3C Proteases/Coronavirus 3C Proteases/Coronavirus 3C Proteases/*antagonists & inhibitors

  • Source: Science (New York, N.Y.) [Science] 2021 Aug 20; Vol. 373 (6557), pp. 931-936. Date of Electronic Publication: 2021 Jul 20.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.

  • Authors : Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.

Subjects: Drug Repositioning* ; COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: Science (New York, N.Y.) [Science] 2021 Jul 30; Vol. 373 (6554), pp. 541-547. Date of Electronic Publication: 2021 Jun 22.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  63 نتائج ل ""Microbial Sensitivity Tests""